Clinical Trials Browser

Has results × CTL019 chimeric antigen receptor × Clear all

NCT01029366 2023-06-22

CART19 to Treat B-Cell Leukemia or Lymphoma That Are Resistant or Refractory to Chemotherapy

Phase 1 Completed

26 enrolled 10 charts

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Lymphoma, Large B-Cell, Diffuse, Hematologic Neoplasms, Lymphoma, Mantle-Cell

NCT02030834 2023-06-22

Phase IIa Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCRz and 4-Signaling Domains in Patients With Chemotherapy Relapsed or Refractory CD19+ Lymphomas

Phase 2 Completed

63 enrolled 10 charts

Lymphoma, Non-Hodgkin

NCT01626495 2020-03-23

Pedi CART19

Phase 1/2 Completed

73 enrolled 12 charts

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell